RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 74 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $113,000 | -86.3% | 20,520 | -55.5% | 0.00% | -76.9% |
Q3 2021 | $824,000 | +943.0% | 46,076 | +345.5% | 0.01% | +550.0% |
Q4 2020 | $79,000 | -66.9% | 10,343 | -78.3% | 0.00% | -80.0% |
Q3 2020 | $239,000 | +132.0% | 47,772 | +178.2% | 0.01% | +100.0% |
Q2 2020 | $103,000 | – | 17,173 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 38,296,526 | $290,671,000 | 5.29% |
HARBOURVEST PARTNERS LLC | 986,878 | $7,490,000 | 2.93% |
Abbot Financial Management, Inc. | 537,000 | $4,076,000 | 2.35% |
Artal Group S.A. | 3,778,913 | $28,682,000 | 0.62% |
HITE Hedge Asset Management LLC | 88,740 | $674,000 | 0.16% |
Virtus ETF Advisers LLC | 33,793 | $256,000 | 0.11% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 394,909 | $2,997,000 | 0.03% |
Baillie Gifford | 4,710,061 | $35,749,000 | 0.02% |
Caption Management, LLC | 86,000 | $652,000 | 0.02% |
Blueshift Asset Management, LLC | 14,626 | $111,000 | 0.01% |